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It has  been  hypothesized (1-3)  that  a  major evolutionary function of the  immune 
system of vertebrates is to recognize and destroy malignant neoplastic cells which are 
postulated to arise spontaneously with a high frequency as a result of somatic mutations. 
According to this hypothesis, then, those neoplasms that are seen as frank tumors must 
either have been naturally selected to avoid detection and destruction by immunosur- 
veillance, or they were allowed to emerge because of some defect in the mechanism of 
immunosurveillance. It now seems quite clear, however, that presentation of an antigeni- 
cally neutral surface is not a universal means that enables tumor cells to avoid detection 
by the immune system. On the contrary, most malignant tumors so far examined have 
been shown to possess tumor-specific antigens,  and to be immunogenic to a  larger or 
lesser  degree  (4-6).  The fact that progressive tumor growth can occur in  spite  of an 
antitumor response on the part of the host is evidence by the numerous examples in 
tumor-bearing animals of concomitant immunity to a tumor cell challenge (reviewed in 
7), and by the demonstrations (8) that tumor-bearing humans and animals can be shown 
to acquire leukocytes that are cytotoxic for tumor cells in vitro. Discovering why immuno- 
surveillance fails to detect and destroy immunogenic tumor cells in the first place, and 
why an acquired mechanism of antitumor resistance fails to destroy a progressive tumor 
in the second place, remain major tasks for tumor immunologists (9). 
In spite  of the  apparent wide  acceptance of the  idea  of a  mechanism of antitumor 
surveillance based on the discriminative powers of the lymphoid system, it is becoming 
increasingly evident that macrophages may also play an important role in protecting the 
host against colonization of its tissues by neoplastic cells.  Indeed, it is no longer possible 
in formulating any hypothesis to explain antitumor surveillance,  to ignore the flood of 
recent publications which show that normal (10) as well as activated macrophages (10-14) 
can recognize and inhibit the growth of neoplastic cells in a  nonimmunological way in 
vitro.  These publications,  together with  the  knowledge that phagocytic cells,  but not 
lymphocytes are possessed by all metazoan animals, allow the suggestion that phagocytic 
cells  are  the  most  likely  candidates  for serving in  a  universal  native  mechanism of 
defense against the emergence of neoplastic cells. 
This  paper  is  the  first  in  a  series  that  will  examine  the  proposition  that 
malignant neoplasms are those neoplasms that are naturally selected to avoid 
detection  and  destruction  by mononuclear phagocytes.  It tests  the  prediction 
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that  any  interference  by  neoplastic  cells  with  the  function  of macrophages 
should be reflected in a reduced capacity on the part of the host to resist infection 
with bacterial  parasites  that are  normally destroyed by macrophages.  It will 
show that subcutaneous injection of murine tumor cells  rapidly results in the 
liberation into the circulation of a factor(s) that strikingly impairs the capacity 
of the  host to express  macrophage-mediated  resistance  against  experimental 
infection  with  the  bacterial  parasites,  Listeria  monocytogenes  and  Yersinia 
enterocolitica. 
Materials and Methods 
Mice.  Breeding stock of all of the inbred strains employed was purchased from The Jackson 
Laboratory,  Bar Harbor,  Maine.  Production of experimental inbred strains and F~ hybrids was 
performed according to established breeding techniques. The F~ hybrids used were (AB6)F~ [A/J x 
C57BL/6], (CB6)F~  [BALB/c × C57BL/6], (AD2)F~  [A/J x  DBA/2j, and (B6D2)F~  [C57BL/6 x  DBA/ 
2].  Mice were employed in experiments when they were between 8 and 12 wk of age. 
Tumors.  The SA1 spindle cell sarcoma syngeneic in the A/J strain, the Meth A flbrosarcoma 
syngeneic in BALB/c, the P-815 mastocytoma and CaD~ mammary carcinoma syngeneic in DBA/2, 
and the EIA lymphoma syngeneic in C57BL/6 were studied. All tumors except the CaD~ mammary 
tumor can be grown in an ascites form.  They were passaged weekly in the peritoneal cavity of 
syngeneic mice and harvested in Dulbecco's phosphate-buffered saline (PBS) ~  containing 1% fetal 
calf serum,  and  10  U  of heparin/ml.  After two  washes  in  PBS they  were  resuspended  to  an 
appropriate concentration in PBS for injection. The CaD2 tumor was passaged subcutaneously by 
trocar. A single cell suspension of tumor cells was obtained by incubating finely diced pieces of the 
tumor at 37°C in modified Puck's saline containing 0.05% trypsin and 0.02% EDTA (Grand Island 
Biological Co., Grand Island, N. Y.). The digest was passed through six layers of sterile surgical 
gauze, and the resulting cell suspension was washed two times and the cells resuspended to an 
appropriate concentration in PBS. In those experiments that employed F~ hybrid mice the tumors 
were first passaged twice in F~ hybrids. 
In most experiments tumor cells were injected subcutaneously in the right-hind foot pad in a vol 
of 0.05  ml  of  PBS.  Tumor  growth  was  followed  by  measuring  changes  in  the  dorso-ventral 
thickness of the foot pad with dial calipers. 
Bacteria.  A  log  phase  culture  of L.  monocytogenes  (strain  EGD)  seeded  from  an  infected 
spleen, was grown in trypticase-soy broth,  and stored in small aliquots at  -70°C.  Before each 
experiment an aliquot was quickly thawed and diluted in a  standard fashion in 0.9%  sodium 
chloride solution for intravenous injection. The organism had a mean lethal dose (LD~,) of 5 x  10  ~ 
by the intravenous route. 
Y. enterocolitica (strain WA) was obtained from Dr. P, B. Carter of the Trudeau Institute, Inc. It 
has an LD.~. of 2  x  10  ~ by the intravenous route.  A  log phase culture,  seeded from an infected 
spleen, was grown in trypticase-soy broth and stored in small aliquots at -70°C. It was prepared 
for intravenous injection in the same way as Listeria. Bacterial growth in the livers was enumer- 
ated by plating 10-fold serial dilutions of whole organ homogenates on trypticase-soy agar. 
Gamma  Irradiation.  Ascites  tumor  cells  were  harvested  in  heparinized  PBS,  washed  two 
times, and suspended at a  concentration of 107/ml  in Fischer's medium (Grand Island Biological 
Co.) containing 10% fetal calf serum. The cell suspension was then placed in large plastic flasks 
and  subjected to  3,000  rad of gamma  irradiation generated by  a  cesium-137  irradiator with  a 
midphantom dose  rate  of 35.5  rads/min.  The  cells  were  then  washed  and  resuspended  at  an 
appropriate concentration in PBS. 
Results 
Rapid Systemic Suppression  of Antibacterial Resistance after Subcutaneous 
Injection  of Tumor  Cells.  It  was  discovered  during  a  study  of nonspecific 
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antitumor resistance generated during experimental bacterial infection, that a 
subcutaneous injection of syngeneic P-815 mastocytoma cells given 1 h  after a 
sublethal intravenous infection with L. monocytogenes  resulted in early death 
from overwhelming  bacterial  growth.  To  determine  whether  the  capacity  to 
rapidly suppress resistance to bacterial infection was a property shared by other 
murine tumors, syngeneic, semisyngeneic, and allogeneic mice were injected in 
the right-hind foot pad with 106 cells of the SA1 spindle cell sarcoma, the Meth A 
fibrosarcoma,  the  P-815 mastocytoma,  the  CaD2  mammary carcinoma,  or the 
EIA lymphoma. 1 h later the mice were injected intravenously with a sublethal 
inoculum of Listeria,  and the growth of the organism in their livers was com- 
pared with its growth in the livers of control mice. 
The results in Figs.  1-3 show that subcutaneous injection of 106 cells of any 
one of the tumors tested resulted  in a  striking  suppression of the capacity of 
syngeneic, semisyngeneic, and allogeneic mice to resist sublethal Listeria infec- 
tion as evidenced by an enormous increase in bacterial growth in their livers. 
All of these mice eventually died from overwhelming infection, in contrast to 
control mice which easily checked the growth of the sublethal inoculum. 
Suppression  of  Antibacterial  Resistance  by  Lethally  Irradiated  Tumor 
Cells.  Fig. 4 shows the results of an experiment which investigated whether a 
foot pad  injection  of l0  s  lethally  irradiated  SA1  cells  can  also  suppress  the 
capacity of (AB6)F1 mice to resist an intravenous sublethal inoculum ofListeria. 
It can be seen from the liver growth curves that lethally irradiated tumor cells 
were just as effective as nonirradiated  tumor cells in causing a  severe impair- 
ment of the capacity of mice to resist sublethal infection. It was also determined 
that these same irradiated cells were incapable of giving rise to a subcutaneous 
tumor. 
Evidence  that  Tumor Cells Interfere  with  the Antibacterial Function  of a 
Normal and an Activated Macrophage System.  The only cell that is known to 
possess the capacity to destroy Listeria in the mouse is the macrophage (15). It 
follows, therefore,  that  the  tumor-induced  suppression  of anti-Listeria  resist- 
ance was caused by interference with the antibacterial function of these phago- 
cytic cells. It can be suggested moreover, that the increase in bacterial growth 
that resulted from subcutaneous injection of tumor cells occurred too early to 
have resulted from a block in the development and expression of T-cell-mediated 
anti-Listeria immunity (16). The increased bacterial growth must have resulted, 
instead,  from  suppression  of  some  pre-existing  mechanism  of antibacterial 
resistance that is expressed very early in infection.  That such a  mechanism of 
native antibacterial resistance is possessed by mice was revealed by the results 
of a previous study (17), which showed that macrophages in the livers of normal 
mice are capable of rapidly destroying over 50% of the Listeria load ingested by 
this organ during the first 8 h  of infection. The same study also showed that a 
much greater rate of destruction of Listeria occurs during the same early time 
period in the livers of mice whose macrophage systems have been activated by 
BCG infection.  This  knowledge  made  it  possible,  therefore,  to  test  whether 
subcutaneous injection of tumor cells suppress the early expression of antibacte- 
rial activity of a  normal and an activated liver macrophage system. Thus, the 
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Fro.  1.  Suppressive effect of a subcutaneous injection of 10  '~ tumor cells on the capacity of 
semisyngeneic mice to resist sublethal intravenous Listeria  infection as determined by 
growth of the parasite in their livers. Subcutaneous injection of cells of any one of five 
tumors given  1 h  before intravenous inoculation with Listeria  resulted in an enormous 
increase in bacterial growth in the liver (solid lines), in contrast to control mice which easily 
checked bacterial growth (broken lines). Means ±  2 SE of five mice per time point. 
first  24  h  of an  intravenous  Listeria  challenge  infection  was  measured  in  the 
livers of normal  (AB6)F1 mice,  and  in the livers of (AB6)F1 mice whose macro- 
phage systems had been activated as a  result of a  12 day BCG infection (17), a  6 
day  Listeria  infection  (18),  or  a  subcutaneous  injection  of Corynebacterium 
parvum  given 7  days previously (19).  In these experiments  the  SA1 cells were 
injected 24 h  before the Listeria  challenge. 
The effect of subcutaneous  SA1 cells on the early destruction of a  sublethal ROBERT  J.  NORTH,  DAVID  P.  KIRSTEIN,  AND  RICHARD  L.  TUTTLE  563 
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FZG.  2.  Same  experiment as  described  for  Fig.  1  except  that  syngeneic mice were  em- 
ployed. 
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Fro.  3.  Same experiment as in Figs. 1 and 2 except that allogeneic mice were employed. 564  SUBVERSION  OF  HOST  DEFENSE  MECHANISMS.  I 
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Fro.  4.  Evidence that subcutaneous injection of 10  ~ lethally irradiated SA1 cells was just 
as effective  as the  same number  of nonirradiated  SA1  cells in  suppressing resistance to 
Listeria  infection as measured by bacterial  growth in the liver.  Means _+  2 SE of five mice 
per time point. 
Listeria inoculum in the livers of normal mice is shown in Fig. 5, where it can be 
seen that the subcutaneous presence of tumor cells greatly impaired the capac- 
ity of normal  liver macrophages to reduce the Listeria load in the liver during 
the first 8 h of infection. Whereas control mice reduced the bacterial load by 0.75 
logs in 8 h, tumor-treated mice achieved only 0.2 log bacterial destruction in the 
same time period. This resulted in a  much larger base for subsequent bacterial 
multiplication,  and consequently in larger numbers of bacteria in the livers at 
later times. 
The suppressive effect of subcutaneous injection of tumor cells on the expres- 
sion of antibacterial capacity of activated liver macrophages is shown in Fig. 6 
where it can be seen that the greatly increased nonspecific antibacterial capac- 
ity expressed over the first 24 h  by BCG-, Listeria-,  and C. parvum-activated 
macrophage  systems were severely impaired.  For instance,  the  capacity of a 
BCG-activated liver macrophage system to kill Listeria over the first 12 h  was 
reduced by 1.5 logs. It will be noted, however, that the bactericidal capacity of 
activated macrophages was not suppressed below that of normal  controls.  An 
above normal antibacterial capacity survived, therefore, in spite of the suppres- 
sive influence of tumor cells. 
Additional Events  in  the Host's Antibacterial Response are  Suppressed  by 
Tumor Cells.  The foregoing results indicate that one way that tumor cells can 
suppress the capacity of mice to resist Listeria infection is by suppressing the 
capacity of resident macrophages of the liver to rapidly kill a significant propor- 
tion of the bacterial inoculum.  To determine whether this was the only reason 
for the increased bacterial growth that follows tumor cell injection,  an experi- 
ment was designed to discover whether increased bacterial growth occurs when 
106 SA1 cells are injected after the initial phase of destruction of Listeria  has 
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Fro.  5.  Evidence that suppressed anti-Listeria resistance that results from subcutaneous 
injection of tumor cells can be caused partly by a  suppressed capacity of resident macro- 
phages of the liver to reduce the bacterial load in this organ during the first 8 h  or so of 
infection. Means _+ 2 SE of five mice per time point. 
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FIG.  6.  Additional evidence to support the interpretation that subcutaneous injection of 
tumor cells suppresses the capacity of phagocytes in the liver to accomplish appreciable 
bacterial  destruction  during  the  early  stages  of infection.  The  greatly  increased  anti- 
Listeria resistance expressed nonspecifically by liver macrophages activated as a  result of 
either BCG, orListeria infection, or by treatment with C. parvum was greatly suppressed by 
subcutaneous injection of 106 SA1 cells.  Means _+ SE of five mice per time point. 566  SUBVERSION  OF  HOST  DEFENSE  MECHANISMS,  I 
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FIG.  7.  Effect on bacterial growth in the liver of subcutaneous injection of SA1 cells given 
at the time of, 24  h  before, or 24 h after initiating Listeria  infection. Only SA1 cells injected 
24 h  before caused suppression of early antibacterial events in the liver.  Suppression of 
antibacterial resistance that occurred when tumor cells were given at later times, therefore, 
was caused by interference with additional antibacterial mechanisms. Means of five mice 
per time point. 
The results in Fig. 7 show that suppression of the early phase of destruction of 
Listeria in the liver only resulted when tumor cells were injected 24 h  before 
infection was initiated. It can be seen that although an injection of tumor cells 
given either at the time of initiating infection, or 24 h  later had no effect on 
bacterial  destruction during  the  first  8  h,  it  did  cause  a  large  increase  in 
bacterial multiplication after about a 24 h delay. It is apparent, therefore, that 
tumor cells can suppress antibacterial mechanisms in addition to those that are 
expressed by resident macrophages during the first 8 h  or so of infection. It is 
also apparent that it takes about 24 h for the subcutaneous deposit of  tumor cells 
to cause systemic suppression of antibacterial resistance. It should be realized 
that it is not until after 24 h of infection that infective foci in the liver become 
heavily populated with monocyte-derived macrophages (20). 
Suppression of Resistance to Infection  with Y. Enterocolitica.  To determine 
whether a  subcutaneous injection of tumor  cells  can  suppress  resistance  to 
infection with bacterial parasites other than Listeria, an experiment was per- 
formed to determine whether resistance to an intravenous Yersinia  infection 
was also suppressed by the injection of tumor cells. Yersinia was chosen for this 
study because of the published knowledge (21) that a  large proportion of an 
intravenous inoculum of this organism is destroyed by normal macrophages of 
the liver during the first 12 h  or so of infection. 
It can be seen in Fig. 8 that subcutaneous injection of 106 SA1 cells into normal 
mice and mice whose macrophage systems had been activated by a 12 day BCG 
infection resulted in a striking reduction in their capacity to destroy Yersinia in 
their  livers  during the  first  8-12  h  of infection.  Suppression  of the  greatly 
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FIG.  8.  Evidence  that  subcutaneous  injection  of tumor  cells  suppresses  resistance  to 
intravenous infection with Y. enterocolitica.  Subcutaneous injection of 10  ~ SA1 cells 24 h 
before intravenous Yersinia challenge greatly decreased the capacity of both a normal and a 
BCG-activated liver macrophage system to destroy the challenge organisms during the first 
12 h  or so of infection. Means _+ SE of five mice per time point. 
vere. As with Listeria, this resulted in a  larger base for subsequent bacterial 
multiplication  and consequently in a higher level of infection at later times. It 
should  be  realized,  however,  that  the  105  Yersinia  inoculum  employed was 
lethal for control mice as well as tumor-treated mice. 
Suppression of Antibacterial Immunity is Mediated by a Factor in Circula- 
tion.  The foregoing results showed that a subcutaneous injection of tumor cells 
in the hind foot pad of mice suppressed their capacity to express antibacterial 
resistance at a remote site. This implied that the effect was caused by a factor in 
circulation.  This possibility was investigated by determining whether an infu- 
sion of serum from tumor-implanted donor mice was capable of suppressing the 
capacity of normal recipient mice to resist Listeria infection.  Syngeneic donor 
mice were bled for serum 24 h after being injected subcutaneously with 106 SA1 
cells. 
Fig. 9 shows that an intraperitoneal  injection of 0.5 ml of serum from tumor- 
treated donors caused a striking suppression of the capacity of normal syngeneic 
recipients to resist sublethal Listeria infection as evidenced by increased bacte- 
rial growth in their livers. Serum from Meth A- and mastocytoma-bearing mice 
was equally active. 
The  Serum  Suppressor Factor is Rapidly  Generated  and Possesses Potent 
Physiological Activity.  The speed at which the suppressor factor appeared in 
the circulation of (AB6)F1 mice after injecting them subcutaneously with tumor 
cells was determined by measuring the capacity of serum collected from them 
at progressive times to suppress antibacterial  resistance in normal  recipients. 
Thus, (AB6)F1 mice were injected with either 105 or 105 SA1 cells and a sample of 
the populations bled for serum at progressive times over 24 h. In all cases, 0.5 ml 
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FIG.  9.  Evidence that tumor-induced suppression of antibacterial resistance is mediated 
by a factor in circulation.  An intraperitoneal infusion of 0.5 ml of serum from 24-h SA1- 
bearing donors caused a striking suppression of the capacity of normal recipients to control 
the growth of a Listeria infection in their livers. Means _+ SE of five mice per time point. 
before injecting them with  2  ×  103 Listeria.  The increase in bacterial  growth 
that  resulted in each case  was  determined by subtracting the  24-h growth  of 
Listeria in the livers of recipients of normal serum from its 24-h growth in the 
livers of recipients of tumor-bearer serum. 
Fig.  10 shows that physiologically active concentrations of suppressor factor 
were present in the circulation within  8 h  of injecting tumor cells subcutane- 
ously,  and  that  the  factor progressively increased  in  concentration until  the 
experiment was terminated at 24 h.  It will be noted that there was very little 
difference between the speed at which the suppressor factor appeared in circula- 
tion of mice injected with 10  '~ and 106 tumor cells. 
A similar assay procedure was used to determine the rate of decay in normal 
recipients of the  suppressive  effect of an intraperitoneal  infusion of 0.5  ml of 
tumor-bearer serum. Normal recipients were infused intraperitoneally with 0.5 
ml of tumor-bearer serum and changes against time in their capacity to resist a 
standard Listeria challenge were followed. 
It can be seen in Fig.  11 that the suppressive effect of an infusion of tumor- 
bearer serum progressively decayed over a 48 h  period, and showed an apparent 
half-life of 24 h. It should be realized that this experiment does not distinguish 
between the decay of the factor as such,  and the decay of its effect. 
The potency of serum collected from 24-h tumor-bearing donors was investi- 
gated by measuring the capacity of limiting dilutions of it to suppress antibacte- 
rial resistance in normal recipients. Thus, serum obtained from donor mice 24 h 
after injecting them subcutaneously with 104 SA1 cells was subjected to twofold 
serial dilution in PBS. Each dilution was injected intraperitoneally into normal 
recipients and their ability to resist a Listeria challenge was then determined. It 
can be seen in Fig.  12 that as little as 0.015 ml of tumor-bearer serum caused a 
significant reduction in the capacity of normal recipients to resist infection with 
a  standard sublethal Listeria inoculum. 
The Tumor Suppressor Factor is Dialyzable.  To obtain an initial idea of the 
size  of the  suppressor  molecule,  its  ability  to  pass  through  a  conventional 
dialysis membrane was investigated. This involved dialyzing one volume of 24-h 
tumor-bearer serum  against  one volume of PBS for 48 h,  and  comparing the ROBERT  J.  NORTH,  DAVID  P.  KIRSTEIN,  AND  RICHARD  L.  TUTTLE 
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FIG, 10.  Speed  of  appearance of  suppressor factor in circulation after injecting either 1{~  ~  or 
10  ~ SA1 cells subcutaneously.  Shown is the increase in 24-h Listeria  growth in  normal 
recipients that resulted from infusion of 0.5 ml of  serum collected from tumor-treated donors 
at the times  indicated  after  injecting  tumor  cells. Appreciable suppressor  activity  was 
present in donor serum within 8 h of injection tumor cells. Means of five mice ± SD. 
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FIG. 11.  Speed  of decay in normal  recipients  of suppressor action of an intraperitoneal 
infusion of 0.5 ml of serum from 24-h tumor-treated  donors. Shown are the increases in 24-h 
Listeria growth in the recipients' livers that occurred when a standard  Listeria inoculum 
was injected at the times indicated after infusing them with tumor-bearer serum. Means - 
SD of five mice per time point. 
ability  of an  intraperitoneal  injection  of the  dialysate  with  the  ability  of an 
injection of the parent serum to suppress resistance to Listeria infection. 
It can be seen from the liver growth curves in Fig. 13 that the serum dialysate 
was just as effective as the parent serum in suppressing resistance to a sublethal 
infection. Therefore, at least part of the suppressive activity of serum is associ- 
ated with a  molecule with a  mol wt of 12,000 or less. 
Discussion 
This  study  shows  that  subcutaneous  injection  of cells  of any  one  of five 
unselected  murine  tumors  resulted  very  rapidly  in  the  liberation  into  the 
circulation  of a  factor(s)  that  severely suppressed  the  capacity of the  host to 
resist intravenous infection with the bacterial parasites, L. monocytogenes and 
Y.  enterocolitica.  It  is  reasonable  to  suggest,  therefore,  that  the  capacity to 
impair resistance to infection with a  spectrum of microorganisms will be found 
to be  a  property shared by many other tumors.  The possibility that a  similar 
mechanism  is  responsible  for the  reported  (22)  high  incidence  of death  from 
natural  infection of terminal  cancer patients  must therefore be  considered.  It 
should  be  realized,  however,  that  death  of experimental  animals  from  acute 570  SUBVERSION  OF  HOST  DEFENSE  MECHANISMS.  I 
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FIG. 13.  Evidence that tumor-suppressor factor is small enough to pass through a dialysis 
membrane. 0.5 ml of serum dialysate was just as effective  as 0.5 ml of the parent serum or 
dialyzed serum in suppressing anti-Listeria  resistance. 
natural infections is not a commonly reported consequence of tumor cell injec- 
tion. The reason for this will be revealed in the paper which follows. 
The major aim of the experiments reported in this paper was to examine the 
proposition that malignant neoplasms are those neoplasms that are naturally 
selected to avoid destruction by the antitumor activity of the host's macrophage 
system. This proposition was suggested on the basis of a large body of published 
experimental evidence (10-14)  which shows that these mononuclear phagocytic 
cells can display potent antitumor activity in vitro. The experiments tested the 
prediction that any interference with the normal function of macrophages by 
neoplastic cells should be reflected in a reduced capacity on the part of the host 
to  resist  experimental  infection  with  those  bacteria  that  are  destroyed by 
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mouse with the capacity to destroy Listeria are macrophages, it follows that the 
systemic suppression of the capacity of mice to resist Listeria infection by tumor 
cells must have been caused by the liberation into the circulation of a factor that 
interfered with the function of these phagocytic cells. Indeed, it was shown that 
subcutaneous injection of tumor cells not only severely suppressed the expres- 
sion of the anti-Listeria activity of macrophages in the livers of normal mice, but 
also suppressed the enhanced, nonspecific, anti-Listeria and anti-Yersinia activ- 
ity of liver macrophage systems that were highly activated as a  result of BCG 
infection, Listeria infection, or by treatment with C. parvum. 
The way in which the tumor-suppressor factor interferes with the function of 
macrophages is not yet known. It either directly suppresses the phagocytic and 
bactericidal activity of these cells, or it indirectly interferes with their ability to 
express these  functions.  Both  possibilities  are  presently under  investigation. 
The finding that the factor severely suppressed the substantial  destruction of 
Listeria that occurs in the liver during the first few hours of infection indicates 
that it can directly interfere with the antibacterial  function of resident macro- 
phages of the liver. The additional finding,  however, that the factor can cause 
increased  growth  of Listeria  when  injected  at  later  stages  of infection  could 
mean  that  it  also  interferes  with  the  function  of monocyte-derived  effector 
macrophages which are known (20) to populate infective foci in the liver in large 
numbers after 24 h of infection. The possibility that the factor interferes with the 
focusing of blood monocytes at infective foci can be suggested on the basis of 
results of another study (to be published) which show that subcutaneous injec- 
tion of the same tumor cells severely reduces the rate at which blood leukocytes 
emigrate  into  sterile inflammatory  peritoneal  exudates.  That  murine  tumors 
produce an anti-inflammatory  factor has been reported by others (23). 
The origin of the suppressor factor is not known. It is either a direct product of 
tumor cells, or tumor cells trigger its synthesis by the host.  The findings that 
subcutaneous  injection  with  as  few  as  105  or  106  tumor  cells  can  result  in 
suppressive concentrations of the factor in blood within 8 h, and that an infusion 
of as  little  as  0.015  ml  of serum  from  24-h  tumor-bearing  donors  severely 
suppressed  the  antibacterial  capacity of normal  recipients,  indicate  that  the 
factor  is  very rapidly  synthesized,  and  that  it  possesses potent  physiological 
activity. It should be realized in this connection that an infusion of 0.015 ml of 
tumor-bearer  serum  into  a  normal  recipient  mouse  represents  a  dilution  of 
about 1 in 300 of the factor in the recipient's blood. 
The chemical identity of the factor is currently being investigated.  All that 
can be stated at this time is that the suppressive activity is associated with a 
molecule that is small enough to pass through a cellophane dialysis membrane. 
The possibility exists that the factor is a prostaglandin,  particularly since these 
compounds  can  be present  in  above normal  concentrations  in  tumor-bearing 
individuals (24). It is unlikely, on the other hand,  that the factor is a corticoste- 
roid. This can be tentatively concluded from the knowledge (25) that relatively 
large quantities of corticosteroids are required to suppress anti-Listeria resist- 
ance; quantities too large to be accommodated in as little as 0.015 ml of serum. 
Again,  whereas the amount of corticosteriod required to suppress anti-Listeria 
resistance results in pronounced atrophy of lymphoid tissue (26) no such atrophy 572  SUBVERSION  OF  HOST  DEFENSE  MECHANISMS.  I 
results from infusions of factor-containing serum (unpublished observations). It 
should be pointed out that injections of normal liver and kidney cells had no 
effect on the capacity of mice to resist Listeria  infection. 
Summary 
The  subcutaneous  injection  of cells  of any  one  of five unselected  murine 
tumors resulted very rapidly in the liberation into the circulation of a  small 
molecular weight factor that severely impaired the capacity of the host to resist 
experimental infection with Listeria monocytogenes and Yersinia enterocolitica. 
It was found that the factor appeared in blood within 8 h of injecting tumor cells 
subcutaneously. That it possessed potent physiological activity was evidenced 
by the demonstration that an infusion of as little as 0.015 ml of tumor-bearer 
serum strikingly suppressed the capacity of normal recipients to resist bacterial 
infection. It was reasoned on the basis of the knowledge that the only cells in 
mice with the capacity to destroy Listeria are macrophages, that suppression of 
antibacterial resistance was caused by the ability of the tumor-suppressor factor 
to  interfere, either directly or indirectly, with the  antibacterial  functions of 
these mononuclear phagocytic cells. The results are consistent with the hypoth- 
esis that at least some malignant neoplastic cells are naturally selected to avoid 
destruction  by  native  and  acquired  antitumor  mechanisms  of mononuclear 
phagocytes. 
Received for publication 26 November 1975. 
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